Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
filingDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b83574349394ef6b387f0208297965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68c41d71b32aac4056be4d5d5715f63c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b937357d237ca3cf971d03bbb70e6fe6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c86281668d20846ae67ead8554b3800 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a3f60743184482eb5db248c7b85ef8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d52cf4240d0b5116baa99eb2e1bb31 |
publicationDate |
2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013172362-A1 |
titleOfInvention |
Imidazothiazole Derivatives Having Proline Ring Structure |
abstract |
Compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and that exhibit anti-tumor activity are provided. Compounds provided by the present disclosure include imidazothiazole derivatives that inhibit interaction between Mdm2 protein and p53 protein and exhibit anti-tumor activity. |
priorityDate |
2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |